Pharmafile Logo
Pharmafocus logo
Advanced Search

Herceptin

Showing 15 posts of 53 posts found.

Perjeta image

Perjeta becomes first approved drug for early breast cancer

October 1, 2013
Sales and Marketing FDA, Herceptin, Perjeta, Roche

Roche’s Perjeta has become the first preoperative breast cancer drug to be authorised by the FDA after it was granted …

News
Herceptin

Roche’s new Herceptin jab approved by NHS

September 25, 2013
Sales and Marketing Herceptin, Kadcyla, Roche, breast cancer

News
herceptin image

EU green light for ‘new’ Herceptin

September 3, 2013
Sales and Marketing EU, Herceptin, Roche, breast cancer

 Roche has ticked another approval off Herceptin’s list with the news that the European Commission is allowing a new form …

News
Roche building

Roche abandons Herceptin patents in India

August 19, 2013
Medical Communications, Sales and Marketing Biocon, GSK, Herceptin, India, Nexavar, Roche, biosimilar

News
Tyvber image

GSK and Roche get EU breast cancer indication

August 15, 2013
Sales and Marketing GSK, Herceptin, Roche, Tyverb, Xeloda, breast cancer

The European Commission has granted a new indication for the use of GSK’s breast cancer drug Tyverb in combination with …

News
herceptinbank

FDA approves Kadcyla

February 25, 2013
Herceptin, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug Kadcyla has been approved by the FDA, giving it hope of replacing revenue …

News
Roche image

Roche’s Perjeta increases survival

June 27, 2012
Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer

Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …

News
Herceptin image

New data shows Herceptin’s ability to increase survival

April 24, 2012
Research and Development, Sales and Marketing Cancer, Cochrane, Herceptin, Roche, breast

A new review of Roche’s breast cancer drug Herceptin has confirmed its ability to increase overall survival, but concerns remain …

News
Roche image

Roche to submit Herceptin successor to regulators

April 2, 2012
Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda

Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …

News
Roche picture

Indian CMO will make Roche blockbusters

March 6, 2012
Manufacturing and Production Emcure, Herceptin, India, MabThera, Pegasys, Roche

Roche has reportedly signed an agreement with Emcure Pharmaceuticals of India that will see the latter manufacturing its blockbuster drugs …

News
Tyverb picture

GSK pulls Tyverb extension in Europe

February 17, 2012
Sales and Marketing GSK, Herceptin, Tyverb, Xeloda

GlaxoSmithKline has withdrawn its European application to extend the licence of its breast cancer pill Tyverb. The firm was seeking …

News
Herceptin and Tyverb image

NICE cannot recommend breast cancer drugs

February 14, 2012
Sales and Marketing GSK, Herceptin, NHS, NICE, Roche, Tyverb

NICE is not recommending GlaxoSmithKline’s Tyverb or Roche’s Herceptin for use in certain breast cancer patients. The watchdog said in …

News
Roche picture

FDA grants Roche’s pertuzumab priority review

February 10, 2012
Sales and Marketing Herceptin, Roche, pertuzumab

The FDA has accepted Roche’s potential breast cancer treatment pertuzumab for appraisal and granted the drug priority review. The proposed …

News
Herceptin image

Injectable Herceptin proves its worth

October 20, 2011
Research and Development, Sales and Marketing Herceptin, Roche

An injectable version of Roche’s breast cancer drug Herceptin compares favourably to the standard intravenous infusion, according to new research. …

News

Roche’s Herceptin successor impresses at EMCC

September 27, 2011
Research and Development Herceptin, Roche, TDM-1

Roche’s next-generation breast cancer drug T-DM1 has impressed at the European cancer congress after besting Herceptin in a new study. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025